Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.380
-0.080 (-5.48%)
At close: Apr 28, 2026, 4:00 PM EDT
1.410
+0.030 (2.17%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $390.27 million as of April 28, 2026. Its market cap has increased by 544.22% in one year.
Market Cap
390.27M
Enterprise Value
166.07M
1-Year Change
544.22%
Ranking
Category
Stock Price
$1.38
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $390.27M, a decrease of -82.78%. That is a compound annual growth rate of -31.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 412.89M | -39.68% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 446.45M |
| Eupraxia Pharmaceuticals | 444.11M |
| Lexeo Therapeutics | 438.60M |
| Neurogene | 438.49M |
| Atea Pharmaceuticals | 437.40M |
| Benitec Biopharma | 435.04M |
| Vanda Pharmaceuticals | 421.44M |
| Neumora Therapeutics | 414.70M |